1. Federal exam “EPS EXPERT/-E EN CYTODIAGNOSTIC”:The federal exam ‘EPS expert cytodiagnostics’ stayed the main topic also of the second annual meeting. After the last meeting a letter was sent to OdaSanté pointing out the tremendous costs of the exam. OdaSanté asked us to submit concrete suggestions on how to reduce costs by October. A meeting of OdaSanté and members of the sponsorship for the exam will take place in December to discuss the propositions.
1. Federal exam “EPS EXPERT/-E EN CYTODIAGNOSTIC”:The date for the next exam has been postponed to 2020 and will not place as originally planned in 2019 (https://www.epsante.ch/fr/professions/eps-experte-en-cytodiagnostic/). The excessive administrative costs of the exam led to this postponement. As of now, the Swiss Federation only covers 60% of the exam costs and not as initially projected 80%.
The first meeting of the Cytopathology Working Group was held at the Institute of Pathology on November 16th 2017 in Lausanne.
After a panel discussion on quality control in OBGYN cytology based on the propositions submitted by the College of American Pathologists in 2013, the following quality control indicators were adopted:
Comme vous le savez peut-être déjà, le journal officiel de l’International Academy of Cytology, ACTA CYTOLOGICA, a été retiré de la Science Citation Index Expandend™ et pour cette raison a perdu son impact factor (IF)(voir aussi Publisher’s Note dans le 60th Anniversary issue).
Nous sommes fiers d’avoir enfin posé la première pierre. Les trois premières candidates ont réussi avec succès le plus haut examen helvétique de notre spécialité et sont maintenant autorisées porter le titre d'expert-e EPS en Cytodiagnostic, avec fierté.
